🇺🇸 REGENERON PHARMACEUTICALS, INC.REGN

Earnings Form 8-K 06-10-2026 07:51:50 EDT

Subject: 8-K Items 1.01, 2.02, 8.01

Overview: Entered a Sixth Amendment to a collaboration agreement with Sanofi for $1.0 billion upfront and up to $7.0 billion in milestone payments.

Source: SEC EDGAR · Original filing

Open document in a new tab

Get filings like this in Telegram the moment they are published — for the companies you follow.

Start 30-day trial About Finterest